science

Dear Research Advocate: What does the current political impasse in Washington have in common with deadly or disabling diseases? They will not cure themselves, and the harm escalates until the “patient” gets expert treatment. There is no place for miracle cures or wishful thinking. The solution isn’€™t what a given individual or party wants it to be, it’€™s what solves the problem. Right now, it’€™s by no means clear what or who will solve the problems ’€” which now include the debt ceiling as well as the lack of funding to run the government. Fasten your seat belts for more turbulence between now and October 17th. You may have heard that the House passed a bill yesterday to fund NIH, along...
Dear Research Advocate: What does the current political impasse in Washington have in common with deadly or disabling diseases? They will not cure themselves, and the harm escalates until the “patient” gets expert treatment. There is no place for miracle cures or wishful thinking. The solution isn’€™t what a given individual or party wants it to be, it’€™s what solves the problem. Right now, it’€™s by no means clear what or who will solve the problems ’€” which now include the debt ceiling as well as the lack of funding to run the government. Fasten your seat belts for more turbulence between now and October 17th. You may have heard that the House passed a bill yesterday to fund NIH, along...
By Bart Peterson, JD, senior vice president of corporate affairs and communications at Lilly I recently had a wonderful opportunity to address the National Health Research Forum, hosted by Research!America. As you may know, this important forum brings together leaders from the public and private sectors to discuss pressing matters that affect the future of research and development in our country. As I mentioned in my speech, from 2000-2007 I had the honor of serving as the mayor of Indianapolis. Although Indianapolis has a solid economic base, I often wondered how other cities in my home state would fare in the headwinds of diverse economic challenges. Indiana is dotted with cities of fewer...
By Bart Peterson, JD, senior vice president of corporate affairs and communications at Lilly I recently had a wonderful opportunity to address the National Health Research Forum, hosted by Research!America. As you may know, this important forum brings together leaders from the public and private sectors to discuss pressing matters that affect the future of research and development in our country. As I mentioned in my speech, from 2000-2007 I had the honor of serving as the mayor of Indianapolis. Although Indianapolis has a solid economic base, I often wondered how other cities in my home state would fare in the headwinds of diverse economic challenges. Indiana is dotted with cities of fewer...
Dear Research Advocate: Congress is on the brink of forcing a government shutdown on Tuesday, October 1. The implications of a shutdown are being subsumed by coverage of the political theater taking place. That is an injustice to Americans, who will be affected. History is illustrative on this point. During the 1995 and 1996 shutdowns , the NIH turned away new patients at the Clinical Center. Research studies housed at federal institutions ceased for the duration of the shutdown; researchers and leaders of industry, academia as well as in government agencies were unable to plan effectively, wasting time and money; the CDC was forced to stop disease surveillance programs, leaving us...
Dear Research Advocate: Congress is on the brink of forcing a government shutdown on Tuesday, October 1. The implications of a shutdown are being subsumed by coverage of the political theater taking place. That is an injustice to Americans, who will be affected. History is illustrative on this point. During the 1995 and 1996 shutdowns , the NIH turned away new patients at the Clinical Center. Research studies housed at federal institutions ceased for the duration of the shutdown; researchers and leaders of industry, academia as well as in government agencies were unable to plan effectively, wasting time and money; the CDC was forced to stop disease surveillance programs, leaving us...
Excerpt of an article by Ariana Eunjung Cha, published in the The Washington Post . A year ago, Yuntao Wu was on a roll. The George Mason University researcher had just published a study hailed by the scientific press as ’€œgroundbreaking’€ that reveals why HIV targets only a specific kind of T-cell and, separately, found that a compound in soybeans seemed to have promise for inhibiting infection. These days, Wu ’€” one of thousands of scientists who lost his grant in the wake of sequester cuts ’€” says he spends much of his time hunched over a desk asking various people and organizations for money. The deep across-the-board cuts in government spending that took effect March 1 have sent...
Excerpt of an article by Ariana Eunjung Cha, published in the The Washington Post . A year ago, Yuntao Wu was on a roll. The George Mason University researcher had just published a study hailed by the scientific press as ’€œgroundbreaking’€ that reveals why HIV targets only a specific kind of T-cell and, separately, found that a compound in soybeans seemed to have promise for inhibiting infection. These days, Wu ’€” one of thousands of scientists who lost his grant in the wake of sequester cuts ’€” says he spends much of his time hunched over a desk asking various people and organizations for money. The deep across-the-board cuts in government spending that took effect March 1 have sent...
Advocacy Academy participants: Mesias Pedroza, PhD, Baylor College of Medicine; Chloe N. Poston, PhD, Eli Lilly and Company; Jeffery G. Mellott, PhD Northeast Ohio Medical University Last week, we held our inaugural Advocacy Academy, bringing 12 postdoctoral researchers from across the U.S. to Washington, D.C. A two-day advocacy training program that culminated in Congressional visits with the participants’€™ representatives. We selected this group of motivated and concerned early-career scientists from a diversity of institutions, including Northeast Ohio Medical University, UCSF, Memorial Sloan-Kettering Cancer Center, Baylor College of Medicine, the University of Pennsylvania School of...
Advocacy Academy participants: Mesias Pedroza, PhD, Baylor College of Medicine; Chloe N. Poston, PhD, Eli Lilly and Company; Jeffery G. Mellott, PhD Northeast Ohio Medical University Last week, we held our inaugural Advocacy Academy, bringing 12 postdoctoral researchers from across the U.S. to Washington, D.C. A two-day advocacy training program that culminated in Congressional visits with the participants’€™ representatives. We selected this group of motivated and concerned early-career scientists from a diversity of institutions, including Northeast Ohio Medical University, UCSF, Memorial Sloan-Kettering Cancer Center, Baylor College of Medicine, the University of Pennsylvania School of...

Pages

Sidebar Quote

Public sentiment is everything. With public sentiment, nothing can fail; without it nothing can succeed.
Abraham Lincoln